On Monday, the Appellate Board upheld the compulsory licence granted to domestic firm Natco Pharma last year, against Bayer's patented anti-cancer drug Nexavar.
The panel of representatives from various ministries and chaired by B K Singh, director, department of pharmaceuticals, has suggested the government negotiate prices of patented medicines based on reference prices of such drugs in other countries such as Britain, Canada, France, Australia and New Zealand.
While the office of the Drugs Controller General of India is still struggling to accumulate data, compensation had been paid only in 50 per cent of the clinical trial death cases so far, sources said.
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
Charge relates to misuse of dominant position to sell spare parts at high rates.
No ethics committee shall review and accord its approval to a clinical trial protocol without prior registration with the licensing authority, as defined in clause (b) of rule 21.
FM may announce a credit guarantee fund for Farmer Producer Organisations.
Disappointed with past experience, domestic majors even skip giving any memorandum.
Increase in Budgetary allocation likely to be only 5.8%, the lowest in six years
Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.
The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
Health & family welfare ministry's proposal seeks to restrict sale of antibiotics to check self-medication.
Prodded by patent cliff & increasing competition, it files application for foray into injectible oncology segment.
In an e-mailed interview with Business Standard, Mark Lynas says his opposition to GM was divorced from science.
Says company yet to file audited accounts, without which it can't proceed.
The 12th Plan document describes three average annual growth scenarios - 8%, 6-6.5% and 5-5.5 per cent.
Firms could lose licence if products not launched within 6 months of approval.
From the next financial year, the government will utilise the disinvestment proceeds for recapitalisation of banks and for subscribing to the shares of Central Public Sector Enterprises and preferential allotments.
Some UTs to start from April 1 and other transfers to be launched from January.
Executives caused loss of Rs 11 cr, according to police SIT.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances